[1]
A. A. Sihombing and H. Situmorang, “Price Earning Ratio (PER) Analysis, Company Size and Debt To Asset Ratio (DAR) on Capital Structure in Pharmaceutical Companies Listed on the IDX in 2018-2022”, JC, vol. 4, no. 2, Jul. 2023.